HCW Biologics Inc. SEC filings HCWB
HCW Biologics Inc. has 340 filings in SEC EDGAR's recent list, going back to Oct 19, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 24, 2026 (material agreement, unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 9, 2026 | — |
| D | Filing | Oct 8, 2026 | — |
| S-1 | Registration statement | Oct 2, 2026 | — |
| DEF 14A | Proxy statement | Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Sep 24, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2026 | Sep 9, 2026 |
| PRER14A | Filing | Sep 9, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Sep 4, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 8, 2026 | Sep 4, 2026 |
| EFFECT | Filing | Aug 31, 2026 | — |
| CORRESP | Letter to the SEC | Aug 28, 2026 | — |
| S-1/A | Amended registration statement | Aug 28, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2026 | — |
| S-1 | Registration statement | Aug 20, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q/A | Amended quarterly report | Aug 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Restatement
|
Aug 14, 2026 | Aug 10, 2026 |
| D | Filing | Aug 6, 2026 | — |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 29, 2026 | Jul 29, 2026 |
| POS AM | Filing | Jul 16, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 30, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 26, 2026 | Jun 24, 2026 |
| EFFECT | Filing | Jun 18, 2026 | — |
| S-1/A | Amended registration statement | Jun 18, 2026 | — |
| CORRESP | Letter to the SEC | Jun 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 15, 2026 |
| UPLOAD | Letter from the SEC | Jun 12, 2026 | — |
| D | Filing | Jun 8, 2026 | — |
| S-1 | Registration statement | Jun 8, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 22, 2026 |
| 8-K |
Current report
Agreement ended
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| POS AM | Filing | May 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| POS AM | Filing | May 13, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Other events
|
Apr 30, 2026 | Apr 29, 2026 |
| EFFECT | Filing | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Apr 28, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| S-1/A | Amended registration statement | Apr 24, 2026 | — |
| S-1 | Registration statement | Apr 23, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 16, 2026 | Apr 15, 2026 |
| DRS | Filing | Apr 13, 2026 | — |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 17, 2026 | Mar 16, 2026 |
| DEF 14A | Proxy statement | Mar 13, 2026 | Mar 13, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 2, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 19, 2026 | Feb 17, 2026 |
| 424B4 | Prospectus | Feb 19, 2026 | — |
| EFFECT | Filing | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| S-1/A | Amended registration statement | Feb 17, 2026 | — |
| S-1/A | Amended registration statement | Feb 13, 2026 | — |
| 8-K |
Current report
Material agreement
|
Feb 13, 2026 | Feb 12, 2026 |
| CORRESP | Letter to the SEC | Feb 11, 2026 | — |
| CORRESP | Letter to the SEC | Feb 11, 2026 | — |
| S-1 | Registration statement | Feb 11, 2026 | — |
| EFFECT | Filing | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| S-1 | Registration statement | Jan 9, 2026 | — |
| 8-K |
Current report
Other events
|
Dec 31, 2025 | Dec 30, 2025 |
| DRS | Filing | Dec 19, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 20, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Material agreement
|
Nov 19, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 18, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 16, 2025 | Oct 13, 2025 |
| DRS | Filing | Oct 1, 2025 | — |
| 8-K |
Current report
Material agreement
|
Sep 5, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 19, 2025 | Aug 19, 2025 |
| 10-Q | Quarterly report | Aug 18, 2025 | Jun 30, 2025 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 18, 2025 | Aug 14, 2025 |
| NT 10-Q | Filing | Aug 15, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 15, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 1, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 23, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Other events
|
Jun 13, 2025 | Jun 12, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 13, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 4, 2025 | May 29, 2025 |
| 8-K |
Current report
Other events
|
May 30, 2025 | May 28, 2025 |
| 8-K |
Current report
Other events
|
May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 8-K |
Current report
Other events
|
May 20, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
May 15, 2025 | May 13, 2025 |
| 424B4 | Prospectus | May 15, 2025 | — |
| EFFECT | Filing | May 13, 2025 | — |
| S-1/A | Amended registration statement | May 13, 2025 | — |
| CORRESP | Letter to the SEC | May 13, 2025 | — |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| CORRESP | Letter to the SEC | May 9, 2025 | — |
| S-1 | Registration statement | May 9, 2025 | — |
| UPLOAD | Letter from the SEC | May 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 17, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DRS | Filing | Apr 28, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 22, 2025 | Apr 17, 2025 |
| EFFECT | Filing | Apr 16, 2025 | — |
| 424B3 | Prospectus | Apr 16, 2025 | — |
| CORRESP | Letter to the SEC | Apr 15, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 14, 2025 | Apr 14, 2025 |
| UPLOAD | Letter from the SEC | Apr 8, 2025 | — |
| S-1 | Registration statement | Apr 7, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 1, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 1, 2025 | Apr 1, 2025 |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 19, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Listing notice
|
Mar 6, 2025 | Mar 3, 2025 |
| CT ORDER | Filing | Feb 26, 2025 | — |
| DEFR14A | Filing | Feb 26, 2025 | — |
| DEF 14A | Proxy statement | Feb 21, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 21, 2025 | Feb 20, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 11, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Feb 7, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Dec 23, 2024 | Dec 17, 2024 |
| D | Filing | Dec 5, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 22, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 22, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 18, 2024 |
| 424B2 | Prospectus | Nov 20, 2024 | — |
| 8-K |
Current report
Material agreement, New debt
|
Nov 18, 2024 | Nov 18, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Auditor change
|
Sep 20, 2024 | Sep 20, 2024 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Aug 23, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 12, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 20, 2024 | Jun 17, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 14, 2024 |
| ARS/A | Filing | May 20, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 10-K/A | Amended annual report | May 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Restatement
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Other events
|
May 1, 2024 | Apr 25, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 14, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| D | Filing | Feb 27, 2024 | — |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 22, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Agreement ended
|
Jan 12, 2024 | Jan 12, 2024 |
| 4 | Insider transaction | Dec 11, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Dec 11, 2023 | Dec 8, 2023 |
| 4 | Insider transaction | Nov 20, 2023 | Nov 17, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 4 | Insider transaction | Oct 23, 2023 | Oct 19, 2023 |
| 4 | Insider transaction | Sep 18, 2023 | Sep 14, 2023 |
| 4 | Insider transaction | Sep 15, 2023 | Sep 13, 2023 |
| 4 | Insider transaction | Sep 15, 2023 | Sep 13, 2023 |
| 4 | Insider transaction | Sep 13, 2023 | Sep 11, 2023 |
| 4 | Insider transaction | Sep 12, 2023 | Sep 8, 2023 |
| 4 | Insider transaction | Sep 8, 2023 | Sep 7, 2023 |
| 4 | Insider transaction | Sep 7, 2023 | Sep 5, 2023 |
| 4 | Insider transaction | Sep 7, 2023 | Sep 6, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HCWB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miramar, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1828673
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.